Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
295
-
Total 13F shares, excl. options
-
9.97M
-
Shares change
-
+241K
-
Total reported value, excl. options
-
$2.82B
-
Value change
-
+$76.8M
-
Put/Call ratio
-
2.11
-
Number of buys
-
159
-
Number of sells
-
-121
-
Price
-
$282.98
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q2 2021
342 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q2 2021.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 295 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.97M shares
of 10.9M outstanding shares and own 91.36% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.78M shares), VANGUARD GROUP INC (1.44M shares), RENAISSANCE TECHNOLOGIES LLC (895K shares), DIMENSIONAL FUND ADVISORS LP (380K shares), STATE STREET CORP (371K shares), RICE HALL JAMES & ASSOCIATES, LLC (303K shares), GEODE CAPITAL MANAGEMENT, LLC (222K shares), Bank of New York Mellon Corp (217K shares), PRINCIPAL FINANCIAL GROUP INC (213K shares), and ACADIAN ASSET MANAGEMENT LLC (195K shares).
This table shows the top 295 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.